Filing Flows › Myomo (MYO) › Q2 2026 › vs Q1 2026
Myomo (MYO) Q2 2026 vs Q1 2026 (quarter over quarter)
Myomo's revenue rose $1.6M (+16%) from $10.1M in Q1 2026 to $11.7M in Q2 2026.
Myomo, Q2 2026: revenue $11.7M (+21% year over year), operating margin -19.3%, net loss $4.0M, operating cash flow −$1.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $11.7M | $10.1M | $1.6M | +16% |
| Net loss | $4.0M | $3.0M | $1.0M | +34% |
| Costs & expenses | $15.7M | $13.5M | $2.3M | +17% |
| Operating costs | $14.0M | $13.3M | $689K | +5% |
| Interest & other, net | $1.7M | −$334K | $2.1M | — |
| Income tax | $31K | $187K | −$155K | -83% |
| Cost of revenue | $3.3M | $3.2M | $50K | +2% |
| Research & development | $1.7M | $1.6M | $97K | +6% |
| Sales & marketing | $5.3M | $4.8M | $447K | +9% |
| General & admin | $3.7M | $3.6M | $94K | +3% |
| Operating cash sources | $4.0M | $3.0M | $1.0M | +34% |
| Depreciation & amortization | $385K | $292K | $93K | +32% |
| Share-based compensation | $1.0M | $597K | $445K | +75% |
| Working capital & other | $650K | −$77K | $726K | — |
| Cash used in operations | $1.9M | $2.2M | −$253K | -12% |
| Net loss absorbed | $4.0M | $3.0M | $1.0M | +34% |
Questions
How much did Myomo's revenue grow quarter over quarter in Q2 2026?
Myomo's revenue rose $1.6M (+16%) from $10.1M in Q1 2026 to $11.7M in Q2 2026.